Led by an experienced and committed team

Our team brings decades of collective expertise in clinical and drug development, ensuring comprehensive knowledge and experience in advancing innovative therapies.

Bas van der Baan
CEO & President

Biotechnology Executive with more than 20 years experience in bringing innovation to the patient. Most recently the Chief Clinical Officer of Agendia.

Specialized in precision oncology and business development. Extensive experience in clinical development overseeing numerous clinical trials from start to publication.

John Kovach, MD
CSO & Exec Chair

Extensive experience in oncology research, established the Long Island Cancer Center, Exec. Vice President for Medical and Scientific Affairs at the City of Hope National Medical Center.

Directed the Cancer Pharmacology Division at the Mayo Clinic. 100+ articles on molecular biology and treatment of cancer.

James Miser, MD

Globally recognized expert in childhood cancer research and treatment.

Extensive experience in clinical development, significant contributions to pediatric clinical cancer studies.

Dr. Miser’s valuable insights and expertise drive our innovative treatments.

Eric Forman, Esq

Extensive expertise in intellectual property, licensing, and corporate transactions.

B.A. degree Cum Laude and a J.D., active member of the New York State Bar Association.

Mr. Forman’s contributions are pivotal in driving our operational efficiency and establishing strategic partnerships.

Robert Weingarten

Seasoned CFO and business consultant with 30+ years of finance and compliance.

Strong business background and board membership in public companies. B.A. in Accounting, M.B.A. in Finance, and CPA credentials.

Robert Weingarten plays a vital role in driving our financial strategies and ensuring our regulatory compliance.

Supported by world-class experts

Our Board of Directors is comprised of esteemed business leaders and renowned key opinion leaders in the fields of clinical medicine and oncology.

Prof. René Bernards

  • Leader in the field of molecular carcinogenesis
  • Extensive experience in cancer drug development
  • Cancer Institute in Amsterdam

Stephen Forman, MD

  • Internationally recognized expert in hematological cancers
  • Professor of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center

Regina Brown, CPA

  • Accountant with decades of expertise
  • Compliance, taxation and internal control implementation

Yun Yen MD, PhD, FACP

  • Distinguished cancer investigator
  • Former Chairman Mol. Pharmacology City of Hope
  • Former President of Taipei Medical University

Bas van der Baan

  • Internationally recognized business dev. executive
  • 20+ years biotechnology experience
  • Key focus on oncology and diagnostics

John Kovach, MD

  • Internationally recognized oncologist
  • Former director of the Cancer Center at Mayo Clinic
  • Established the Long Island Cancer Center